
Global Brain
Tokyo venture firm that manages TOHO Ventures, a new backer of Oyster Therapeutics in 2026.
Last refreshed: 14 November 2026
Why are Japanese investors backing British Alzheimer's biotech?
Timeline for Global Brain
Oyster brings Eli Lilly into $60m round
UK Startups and InnovationBackground
Global Brain, a Tokyo venture capital firm, manages TOHO Ventures, which joined Oyster Therapeutics' $60m Series A on 10 November 2026 as a new investor. London's 4BIO Capital led the round and Eli Lilly joined as a strategic investor.
Oyster's investor list spans Britain, the United States and Japan. Brain-disease biotech needs that breadth, because few specialist funds will carry a programme alone to first human data.
Global Brain runs funds of its own and manages corporate venture funds on behalf of other companies.
Who manages TOHO Ventures?
Who invested in Oyster Therapeutics?
Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Updated 14 November 2026. Editorial standards.